EXPERIMENTAL TISSUE SHARED RESOURCE

实验组织共享资源（ETR）的主要目标是提供基本的，翻译的， 和癌症中心的临床研究人员获得和分析人类和动物组织。一 一个关键的优势是，这一核心利用了国防部的技术和专业知识， 病理学和实验室医学。目前提供三种服务：i）组织组织学和 免疫组织化学; ii）组织建库;和iii）组织分析，包括激光捕获显微术， 形态测定和图像定量和基因分型服务。由于核心是在前一个 在资助期内，已有63个CFCCC成员使用了它。使用量有所增长，特别是在 组织学/免疫组织化学成分，占ETR内的大部分使用。在 在上一个供资期间，组织学部分以低于市场的收费提供了高质量的服务 52个不同的CFCCC成员主要从事翻译工作， 研究人类癌症标本或研究人类癌症的啮齿动物模型。如果需要，我们 定制服务，满足CFCCC会员的特殊需求。这些特点使我们的 组织学服务比商业供应商提供的服务更上级，有助于使用增长。ETR 在上一个供资期间，组织学服务部门为43份出版物提供了捐助，其中36份使用了组织学服务。 21名CFCCC研究者使用了组织库服务。分析服务，15个国家使用 对于从事转化和临床研究的研究者来说， 项目在这次更新中，我们建议扩大以满足对组织学服务日益增长的需求， 维持我们的专业分析服务，通过专注于加强我们的组织采购活动 全面银行前列腺癌，并提供一个新的小鼠病理学服务，这将有助于 CFCCC研究人员在人类基因工程小鼠模型的初步表征 癌

The primary objective of the Experimental Tissue Shared Resource (ETR) is to provide basic, translational, and clinical researchers within the Cancer Center access to, and analysis of, human and animal tissues. A key advantage is that this Core leverages the technical and professional expertise of the Department of Pathology and Laboratory Medicine. Three services are currently offered: i) tissue histology and immunohistochemistry; ii) tissue banking; and iii) tissue analysis, including laser capture microscopy, morphometry and image quantitation and genotyping services. Since the Core was initiated in the prior funding period, 63 CFCCC Members have used it. There has been growth in use, especially in the histology/immunohistochemistry component, which accounts for the majority of usage within the ETR. In the prior funding period, the histology component has provided high-quality service at below-market recharge rates, with short turn-around times to 52 different CFCCC Members who are mainly pursuing translational research on human cancer specimens or studying rodent models of human cancer. When required, we customized services to meet the special needs of CFCCC Members. These features have made our histology services superior to those available from commercial vendors, contributing to usage growth. ETR services contributed to 43 publications in the prior funding period, including 36 using histology services. Tissue banking services were used by 21 CFCCC investigators. Analytical services, used by 15 investigators, have been particularly valuable to investigators pursuing translational and clinical research projects. In this renewal, we propose to expand to meet an increased demand for histology services, maintain our specialty analytical services, strengthen our tissue procurement activities by focusing on comprehensively banking prostate cancers and provide a new mouse pathology service which will assist CFCCC investigators in the initial characterization of genetically engineered mouse models of human cancer.